Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.1.34 (
lipoprotein lipase
)
7,025
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Nine young, healthy male volunteers were given ethanol (75 g/day) for 5 weeks. The ethanol was divided into five daily doses and taken so that blood ethanol levels never exceeded 0.04% (w/v). During the latter part of the ethanol intake period, there was a significant, transient increase of plasma triglyceride (TG) concentrations followed by reduction to normal levels. A three-fold increase of
lipoprotein lipase
activity (LLA) occurred in biopsy specimens of adipose tissue. An increase of alpha-lipoprotein concentrations, which correlated significantly with the decrease in plasma TG levels and the increase in adipose LLA, was also observed during the ethanol intake period. No changes were observed in plasma cholesterol and beta-lipoprotein levels. A transient, three-fold increase of TG concentrations occurred in liver biopsy specimens. Ultrastructural and cytochemical examinations of the biopsy specimens showed hyperplasia of the smooth
endoplasmic reticulum
, and increased canallicular activity of gamma-glutamyl transferase (gamma-GT) activity in most subjects towards the end of and after the ethanol intake period. Serum gamma-GT levels also increased significantly.
...
PMID:Alterations of lipid metabolism in healthy volunteers during long-term ethanol intake. 1 44
Incubation of cycloheximide-treated cardiac myocytes results in a time-dependent increase in cellular and heparin-releasable
lipoprotein lipase
(
LPL
) activities. N-Methyldeoxynojirimycin (1 mM) and castanospermine (100 micrograms/ml), inhibitors of glucosidases in the
endoplasmic reticulum
(ER), prevented the increase in cellular
LPL
activity. The glucosidase inhibitors did not influence the synthesis or turnover of LPL protein. Therefore activation of
LPL
by glycosylation in cardiac myocytes requires the trimming of glucose residues in oligosaccharide chains by glucosidases of the ER.
...
PMID:Activation of lipoprotein lipase in cardiac myocytes by glycosylation requires trimming of glucose residues in the endoplasmic reticulum. 149 6
The relationship between maturation of
lipoprotein lipase
(
LPL
) and its translocation from the
endoplasmic reticulum
(ER) to the Golgi complex was determined by measuring lipolytic activity under conditions preventing transport of the enzyme from the ER to the Golgi compartment. In the presence of brefeldin A, a reagent that inhibits movement of proteins from the ER and causes the disassembly of the Golgi complex, pro-5 Chinese hamster ovary cells accumulated catalytically active
LPL
, while secretion of the enzyme was effectively blocked.
LPL
retained intracellularly by brefeldin A treatment possessed oligosaccharide chains that were processed to the complex form by the Golgi enzymes redistributed into the ER. At 16 degrees C, a condition disrupting protein transport to the cis-Golgi, the retained enzyme again remained catalytically active although the oligosaccharides remained in the high mannose form. Lastly, attachment of the specific ER retention signal KDEL (Lys-Asp-Glu-Leu) to the carboxyl terminus of
LPL
also resulted in intracellularly retained enzyme that was fully active. The importance of oligosaccharide processing for attainment of
LPL
catalytic activity in vitro was also determined.
LPL
was active and secreted when trimming of the mannose residues was inhibited by deoxymannojirimycin and when addition of complex sugars was blocked using Chinese hamster ovary mutants (lec1 and lec2), indicating that these processing events are not necessary for the expression of a functional enzyme. However, blocking glucose removal by glucosidase inhibitors (castanospermine and N-methyl-deoxynojirimycin) resulted in a significant reduction in
LPL
specific activity and secretion. Thus, glucose trimming of
LPL
oligosaccharides is essential for enzyme activation; however, further oligosaccharide processing or translocation of the enzyme to the cis-Golgi is not required for full expression of lipolytic activity in vitro.
...
PMID:Maturation of lipoprotein lipase. Expression of full catalytic activity requires glucose trimming but not translocation to the cis-Golgi compartment. 155 30
The effect of inhibitors on the glycosylation, activity and secretion of
lipoprotein lipase
was studied in brown adipocytes cultured from newborn mice. Such cells synthesized and secreted active
lipoprotein lipase
. It is generally accepted that active
lipoprotein lipase
is a homodimer. Glycosylation of
lipoprotein lipase
was analysed by PAGE of endoglycosidase H (endo H)-digested subunits of
lipoprotein lipase
immunoprecipitated from cells incubated for 1-2 h with [35S]methionine. The most prevalent 35S-labelled lipase subunit (Mr 57,000-58,000) in these cells contained endo H-resistant oligosaccharide chains, the next most prevalent contained totally endo H-sensitive chains, and the least prevalent subunit contained partially endo H-sensitive chains. Complete blocking of the glycosylation of
lipoprotein lipase
with tunicamycin (1 microgram/ml) for 24 h resulted in synthesis of an inactive non-secretable form of lipase with a smaller subunit (Mr 51,000-52,000). Immunofluorescent studies showed that unglycosylated lipase in tunicamycin-treated cells was retained in the
endoplasmic reticulum
. Cells treated with 1 microM-monensin, an intra-Golgi transport inhibitor, synthesized an active form of lipase which was not secreted, but was retained in the Golgi. The lipase in monensin-treated cells contained only partially or totally endo H-sensitive chains. Blocking either Golgi mannosidase I with 4 mM-1-deoxymannojirimycin or Golgi mannosidase II with 10 microM-swainsonine resulted in production of a form of
lipoprotein lipase
which was active and secreted, and which contained only endo H-sensitive chains. Our findings demonstrate that core glycosylation of
lipoprotein lipase
in the
endoplasmic reticulum
is required for lipase activity and transport from the reticulum, whereas processing of the oligosaccharide chains to endo H-resistant (complex) type chains in the Golgi is not required for either the activity or the secretion of
lipoprotein lipase
.
...
PMID:Glycosylation, activity and secretion of lipoprotein lipase in cultured brown adipocytes of newborn mice. Effect of tunicamycin, monensin, 1-deoxymannojirimycin and swainsonine. 183 51
Long chain fatty acids (FA) and 2-monoacylglycerols (MG) are produced by
lipoprotein lipase
(
LPL
) from plasma triacylglycerols (TG) in capillaries of adipose tissue and transported to adipocytes for TG synthesis. It is widely proposed FA may be transported in cells by FA-binding protein. Mode of transport of MG has received little attention. Our findings in tissues and model membranes indicate that FA (as 1:1 acid-soaps) and MG can be transported in vivo by lateral movement in an interfacial continuum (IFC) of the outer leaflets of plasma and intracellular membranes of capillary endothelium and adipocytes. We postulate that FA and MG enter the IFC in capillaries and flow in the IFC across endothelium and extracellular space to sites in adipocytes where MG are hydrolyzed by MG-lipase (MGL) to FA and glycerol, and FA are esterified in
endoplasmic reticulum
or transferred to inner mitochondrial membrane for oxidation. FA and MG produced by hormone-sensitive lipase also enter the IFC. These MG flow in the IFC to sites of MGL activity, and the FA flow in the IFC to capillaries for transport to other tissues by albumin, or to mitochondria for heat production.
...
PMID:Transport of fatty acids and monoacylglycerols in white and brown adipose tissues. 195 50
Combined lipase deficiency (cld) is a recessive mutation which causes a severe deficiency of
lipoprotein lipase
and hepatic lipase activities and lethal hypertriacylglycerolemia within 3 days in newborn mice. The effect of this genetic defect on
lipoprotein lipase
was studied in primary cultures of brown adipocytes derived from tissue of newborn mice. Cells cultured from cld/cld mice replicated, accumulated triacylglycerol, and differentiated into adipocytes at normal rates. Lipoprotein lipase activity in unaffected cells was detectable on Day 0 of confluence and increased to 1.3 units/mg DNA by Day 6, while that in cld/cld cells was less than 4% of that in unaffected cells on Days 4-6. Unaffected cells released 1.2% of their lipase activity in 30 min in the absence of heparin, and 11% in 10 min in the presence of heparin, whereas cld/cld cells released no lipase activity. cld/cld cells contained 2-3 times as much
lipoprotein lipase
protein as unaffected cells, and released no lipase protein to the medium. Immunofluorescent
lipoprotein lipase
was not detectable in unaffected adipocytes unless lipase secretion was blocked with monesin, causing retention of the lipase in Golgi. cld/cld adipocytes, in contrast, contained immunofluorescent
lipoprotein lipase
distributed in a diffuse reticular pattern, indicating retention of lipase in
endoplasmic reticulum
. Lipoprotein lipase immunoprecipitated from cells incubated 1-3 h with [35S]methionine was digested with or without endoglycosidase H (endo H) or F, and resolved by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Lipoprotein lipase in unaffected cells (Mr = 56,000-58,000) consisted of three glycosylated forms, of which the most prevalent was endo H-resistant, the next was totally endo H-sensitive, and the least was partially endo H-sensitive. In contrast,
lipoprotein lipase
in cld/cld cells (Mr = 56,000) consisted of a single, totally endo H-sensitive form. Lipoprotein lipase in both groups of cells contained two oligosaccharide chains. Chromatography studies with heparin-Sepharose indicated that at least some of the
lipoprotein lipase
in cld/cld cells was dimerized. The findings demonstrate that brown adipocytes cultured from cld/cld mice synthesize
lipoprotein lipase
with two high mannose oligosaccharide chains, but it is inactive and retained in
endoplasmic reticulum
. Whether the cld mutation affects primarily processing of oligosaccharide chains of
lipoprotein lipase
in
endoplasmic reticulum
, transport of the lipase from the reticulum, or some other process, is to be resolved.
...
PMID:Synthesis of inactive nonsecretable high mannose-type lipoprotein lipase by cultured brown adipocytes of combined lipase-deficient cld/cld mice. 210 49
Newborn combined lipase-deficient (cld) mice have severe hypertriglyceridemia associated with a marked decrease of
lipoprotein lipase
(
LPL
) and hepatic lipase (HL) activities. Since the cld mutation and lipase genes reside on separate chromosomes, combined lipase deficiency cannot result from defects occurring within the
LPL
or HL structural genes. To elucidate the biochemical basis of this trans-acting defect, cld mice were compared to unaffected littermates for changes in lipase mRNA levels, rates of synthesis, and posttranslational processing and secretion.
LPL
and HL mRNA levels in cld liver and
LPL
in cld heart were comparable to controls; corresponding lipase synthetic rates were modestly decreased by about 30%. However, these reduced synthetic rates were not lipase-specific, since the rates of apolipoprotein (apo) A-I and apoA-II synthesis in cld liver were similarly decreased. Despite
LPL
synthetic rates that were 70% of controls,
LPL
mass in cld postheparin plasma was markedly reduced to only 7% of control values, suggesting that the majority of
LPL
is not secreted but remains intracellular. Consistent with a lipase secretory defect, neither the
LPL
nor HL oligomannosyl forms were converted to their respective complex forms in cld tissues, indicating that the lipases had failed to move from the
endoplasmic reticulum
/cis-Golgi to the medial/trans-Golgi network. In addition, the majority of intracellular
LPL
was catalytically inactive, since
LPL
specific activity (units/mg LPL protein) in cld heart, kidney, and brain was reduced 80-97%. In contrast to the severe impairment of lipase posttranslational processing and secretion, cld mouse plasma contained normal levels of another secretory N-linked glycoprotein, adipsin, with its oligosaccharide chains fully processed to the complex form. Thus, the cld mutation appears not to globally disrupt the secretion of all N-linked glycoproteins, but rather selectively impairs
LPL
and HL at points essential to their normal intracellular transport and secretion.
...
PMID:Combined lipase deficiency in the mouse. Evidence of impaired lipase processing and secretion. 221 73
The regulation of adipose tissue
lipoprotein lipase
(
LPL
) was examined in rats fed or fasted overnight, and was found to be controlled posttranslationally.
LPL
catalytic activity decreased by 50% after fasting while
LPL
mRNA levels and rates of synthesis increased nearly 2-fold; enzyme mass remained unchanged. The distribution of
LPL
within the
endoplasmic reticulum
(ER) and Golgi/post-Golgi secretory pathway was assessed by differentiating between
LPL
high mannose and complex forms. After fasting, the majority of
LPL
is in the high mannose ER form (65%, 0.97 micrograms/g wet weight tissue), whereas the
LPL
complex form comprises only 35% (or 0.52 micrograms/g). After refeeding, however, the Golgi-derived
LPL
complex form predominates (65%, 1.03 micrograms/g) over the high mannose ER form (35%, 0.55 micrograms/g). Kinetic analysis suggests that high mannose
LPL
disappears with a half-life of t0.5 = 40 min in both fed and fasted rats, indicating that the redistribution of
LPL
mass during feeding/fasting does not arise by differential retention within ER. Instead, the fractional catabolic rate of complex
LPL
within the Golgi/post-Golgi secretory compartment can be calculated to be 3.5-fold greater in fasting. In heart, changes in
LPL
activity in response to feeding/fasting are also not due to differences in mRNA levels or rates of synthesis. Based on these findings, a model of
LPL
posttranslational regulation is proposed and discussed.
...
PMID:The response of lipoprotein lipase to feeding and fasting. Evidence for posttranslational regulation. 230 76
Previous studies have indicated that the processing of oligosaccharide chains is necessary for
lipoprotein lipase
to become catalytically active and may be involved in the regulation of lipase release. Guinea pig adipocytes and perfused guinea pig hearts were labeled with [35S]methionine, and
lipoprotein lipase
was immunoprecipitated. Digestion with endo-beta-N-acetylglucosaminidase H (Endo H) showed that the mature enzyme contains one high mannose and two complex oligosaccharide chains. Limited proteolysis indicated where in the molecule the chains are attached. Pulse-chase experiments showed that some lipase molecules were rapidly processed and appeared in the medium within 40 min. Other lipase molecules remained fully Endo H-sensitive for more than 2 h, and this form of the lipase did not appear in the medium. Both forms co-eluted with the sole
lipoprotein lipase
activity peak from heparin-Sepharose; this indicates that both were dimeric. Separation of the two forms was achieved by lectin chromatography and demonstrated that both were catalytically active. Cells treated with methyl-deoxynojirimycin or with deoxymannojirimycin produced and released active
lipoprotein lipase
which was fully Endo H-sensitive. These studies demonstrate that the trimming and processing of the oligosaccharide chains is not necessary for
lipoprotein lipase
to become catalytically active and be secreted, and they suggest that a comparatively large fraction of the lipase molecules is retained in the
endoplasmic reticulum
. Whether they ever reach the processing apparatus in the Golgi or are degraded is not clear.
...
PMID:The relation between glycosylation and activity of guinea pig lipoprotein lipase. 252 59
The biosynthesis and turnover of
lipoprotein lipase
(
LPL
) have been investigated in adipose 3T3-F442A cells labeled with [35S]methionine. Pulse-chase experiments, endo-beta-N-acetylglucosaminidase H treatment, and analysis by sodium dodecyl sulfate-polyacrylamide gel electrophoresis have indicated that
LPL
is synthesized in the
endoplasmic reticulum
as a glycoprotein of Mr = 55,500 bearing two N-oligosaccharide side chains of the high mannose-type. This precursor form of
LPL
is transported within 10 min to the Golgi apparatus, and this event is accompanied by the formation of a mature species of Mr = 58,000. Treatment of the Mr = 58,000 species with glycopeptidase F yielded a Mr = 51,000 protein similar to that observed after treatment of the Mr = 55,500 precursor form or after inhibition of N-glycosylation in tunicamycin-treated cells. The precursor form of
LPL
of Mr = 55,500 does not accumulate in the cells since, after a labeling period of 2 h, only the Mr = 58,000 species is detected. It is shown that only 20% of the newly synthesized molecules of Mr = 58,000 are constitutively secreted, whereas 80% are degraded, most likely in lysosomes, as indicated by the inhibitory effect of leupeptin upon the degradation process. Under heparin stimulation, quantitative secretion of the mature form of
LPL
takes place whereas the intracellular degradation is arrested. Heparin is able to mobilize intracellular
LPL
without changing the rate of
LPL
export from the
endoplasmic reticulum
to the cell surface. Sucrose gradient centrifugation of the material from intracellular cisternae shows that the Mr = 55,500 precursor form is present as a monomer (s = 4.1 S), whereas the Mr = 58,000 mature form is present as a homodimer (s = 6.8 S) to which
LPL
activity is associated. The results are interpreted as
LPL
being transiently stored under a dimeric form before its degradation. A sorting process of
LPL
in the Golgi apparatus, followed by its entry either mainly in a regulated pathway or in a constitutive pathway, is proposed.
...
PMID:Biosynthesis of lipoprotein lipase in cultured mouse adipocytes. II. Processing, subunit assembly, and intracellular transport. 275 12
1
2
3
4
5
6
7
Next >>